Merck Contact us
ZOSTAVAX Français    Decrease Text Size Increase Text Size     Print this page  Print Page     Share  Share  

 

ZOSTAVAX

ZOSTAVAX® is the first and only vaccine indicated to help prevent shingles in individuals 50 years of age or older.

ZOSTAVAX® is given as a single-dose injection and works by boosting your immune system to help protect you from shingles.

You should not get ZOSTAVAX® if you are allergic to any of its ingredients, including gelatin or neomycin, have a blood disorder or any type of cancer that weakens your immune system, or already have a weakened immune system, have active untreated tuberculosis, or if you are pregnant.

Most common side effects were at the injection site and included redness, pain, swelling, hard lump, itching, warmth, and bruising. Headache and pain in an arm or leg were also reported.

Talk to your doctor or healthcare professional today to find out how to help protect yourself against shingles and if ZOSTAVAX® is right for you. Click here to download a brochure on ZOSTAVAX®

To learn more about the importance of vaccination, click here.

ZOSTAVAX® is the only vaccine indicated to help prevent shingles in individuals 50 years of age or older.

ZOSTAVAX® does not protect everyone, so some people who get the vaccine may still get shingles. However, if you develop shingles despite being vaccinated, ZOSTAVAX® can help reduce the intensity and duration of pain.
Click here for detailed Consumer Information
on ZOSTAVAX® or the ZOSTAVAX® Product Monograph.
Home What is Shingles? What is ZOSTAVAX®? Where you can get vaccinated Related Links Watch our TV Spot Photo Gallery Contact Us Site Map

Merck

PAAB This site is intended for Canadian residents only.
® Registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Used under licence.
© 2009-2012 Merck Canada Inc., a subsidiary of Merck & Co., Inc. All rights reserved.